Friday, May 27, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Role of natural immunity to SARS-CoV-2 on post-vaccination antibody responses in staff and residents of long-term care facilities

by Medical Finance
in Coronavirus
Study: Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff. Image Credit: Corona Borealis Studio/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that has led to the coronavirus disease 2019 (COVID-19) pandemic, has caused 400 million infections throughout the world, with 78 million infections in the United States (US) alone. Two million of those infections are reported in staff and residents of long-term care facilities (LTCFs). They represent around 16% of total deaths in the US.

Study: Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff. Image Credit: Corona Borealis Studio/Shutterstock
Study: Impact of prior infection on SARS-CoV-2 antibody responses in vaccinated long-term care facility staff. Image Credit: Corona Borealis Studio/Shutterstock

Background

LTCFs are considered high-risk environments due to their congregant living setting and the presence of multiple comorbidities. Therefore, LTCFs were kept at the forefront in surveillance testing as well as were the first groups to receive vaccines when they were available. Over 80% of staff and residents were vaccinated as reported till February 2022 in the country.

However, before vaccines and other preventative measures were available, the staff and residents suffered high infection rates, with seroprevalence rates as high as 40%. Therefore, two immunologically distinct groups were available for vaccination, those that were naïve, with no evidence of prior infection (seronegative), and those that were pre-immune due to prior infection (seropositive).

Several studies suggested that the level of binding antibodies was much higher in seropositive individuals than in seronegative ones following the first dose of the vaccine. Similar results were also found post the second dose. However, studies on the polyclonal antibody neutralization of the live SARS-CoV-2 virus did not occur.

A new study published in pre-print server bioRxiv* collected and analyzed sera from the staff at a local long-term care facility (LTCF) from August to December 2020, where an outbreak occurred in September 2020. The study also analyzed the samples collected from the staff following vaccination from February to September 2021 to determine the impact of prior infection on vaccination.

About the study

The study involved staff at a local LTCF from whom blood samples were collected. The blood samples were then allowed to clot, followed by separation of sera. The sera were heat-inactivated at 56°C for 30 minutes and stored at 4°C.

Vero cells were used for SARS-CoV-2 infection. Standard plaque reduction neutralization test (PRNT) was performed where diluted sera were mixed with the virus, incubated, and added to a Vero cell monolayer. This was again followed by incubation. After that, binding assays were performed, followed by surveillance qPCR testing.

Study findings

The results indicated that individuals who were previously infected had higher levels of neutralizing antibodies following administration of the first dose of vaccine than seronegative individuals. The receptor-binding domain (RBD) antibody binding levels reached a maximum level at 70 days post-vaccination for all individuals. The difference in RBD levels for seropositive and seronegative individuals was not as significant as the neutralizing antibodies level.

Individuals with detectable nucleoprotein (NP) binding antibodies were suggested to have a prior SARS-CoV-2 infection since there was no nucleoprotein component in the vaccine. Additionally, the neutralizing and RBD binding antibody levels were significantly increased in seronegative individuals following the second dose of the vaccine. However, the neutralizing, RBD binding, and NP binding antibody levels remained unchanged for pre-vaccination seropositive individuals.

The results also reported a strong relationship between the neutralizing titer and RBD binding antibody in post-vaccination sera samples independent of the immune status. However, the relationship was poorly correlated in the case of nucleoprotein antibodies. Furthermore, only one individual in the cohort was reported to experience a breakthrough infection post-vaccination.

Conclusion

Therefore, the current study demonstrates that a prior infection significantly increases SARS-CoV-2 antibody responses following vaccination. The levels of both neutralizing and RBD binding antibody levels were found to increase following the first dose of the vaccine. However, these levels remained almost unchanged following the second dose. Breakthrough infection was reported only in one individual who had received both vaccine doses. This suggests the importance of booster doses to further protect against severe disease. Variant-specific booster doses are now an important measure for maintaining long-term immunity against SARS-CoV-2.

*Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time. Image Credit: Maria Sbytova / Shutterstock.com

Adults and children have similar neutralizing antibody responses to SARS-CoV-2 infection

by Medical Finance
May 27, 2022
0

In a recent study published on the medRxiv* preprint server, researchers describe the kinetics of severe acute respiratory syndrome coronavirus...

Study: “It affects every aspect of your life”: A qualitative study of the impact of delaying surgery during COVID-19. Image Credit: Photoroyalty/Shutterstock

Patient-reported impact of having surgery delayed during the COVID-19 pandemic

by Medical Finance
May 27, 2022
0

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the coronavirus (COVID-19) pandemic, which overburdened healthcare systems globally. Several...

Study: Interleukin-1 blocking agents for treating COVID-19. Image Credit: Juan Gaertner / Shutterstock.com

Study finds limited evidence for IL-1 blockers in treating COVID-19

by Medical Finance
May 27, 2022
0

In a recent Cochrane Database of Systematic Reviews study, researchers assess the effectiveness and safety outcomes of interleukin-1 (IL-1) blocking...

OBSERVATIONAL STUDY Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic. Image Credit: Donkeyworx / Shutterstock

Approximately 13% of hospitalized COVID patients have serious neurologic symptoms

by Medical Finance
May 27, 2022
0

It has been established that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes dysfunction throughout the body, including the...

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

National identities play a significant and positive role in battling COVID-19 pandemic

by Medical Finance
May 27, 2022
0

Identification with one's nation predicts both greater engagement with public health behaviors, such as masking and social distancing, and support...

Study: Mitigating Isolation: Further Comparing the Effect of LFD Testing for Early Release from Self-Isolation for COVID-19 Cases. Image Credit: Ian Gessey / Shutterstock.com

Using lateral flow testing to define COVID-19 self-isolation period

by Medical Finance
May 27, 2022
0

A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially...

Next Post
Common member of the gut microbiome found to have specific preference for blood group A antigens

Common member of the gut microbiome found to have specific preference for blood group A antigens

Study: High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site During Prevalent Delta Variant. Image Credit: Cryptographer/Shuttershock

Rapid antigen tests exhibit high accuracy for COVID-19 screening in children

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Glasses and risk of COVID-19 transmission - analysis of the Virus Watch Community Cohort study. Image Credit: DimaBerlin/Shutterstock
    Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses
  • Different CrossMab Crossovers.
    The increasing use of bispecific antibodies in antibody therapeutics
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply